Influence of the coronavirus infectious disease 2019 pandemic on infectious disease practice and infection control in Japan: A web questionnaire survey.

Autor: Mori N; Department of Clinical Infectious Diseases, Aichi Medical University, Aichi, Japan., Mikamo H; Department of Clinical Infectious Diseases, Aichi Medical University, Aichi, Japan. Electronic address: mikamo@aichi-med-u.ac.jp., Mukae H; Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan., Yanagihara K; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan., Kunishima H; Department of Infectious Diseases, St. Marianna University School of Medicine, Kanagawa, Japan., Sasaki J; Department of Emergency and Critical Care Medicine, Keio University School of Medicine, Tokyo, Japan., Yotsuyanagi H; Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Jazyk: angličtina
Zdroj: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Jan; Vol. 30 (1), pp. 1-6. Date of Electronic Publication: 2023 Sep 16.
DOI: 10.1016/j.jiac.2023.09.018
Abstrakt: Introduction: Infection and mortality rates caused by the coronavirus infectious disease 2019 (COVID-19) pandemic were high. However, the influence of the COVID-19 pandemic on the clinical burden in medical facilities remains to be clarified in Japan.
Materials and Methods: This study used a questionnaire-based web survey to clarify how the COVID-19 pandemic affected infectious disease practice and infection control. The questionnaire was sent to healthcare professionals at nationwide medical facilities between January 13, 2023, and February 15, 2023.
Results: Responses were obtained from 1784 healthcare professionals throughout Japan. Hospital management of COVID-19 patients was the responsibility of 96.5% of respondents. Furthermore, 75.1% had experienced nosocomial spread of COVID-19. Manuals and infection control measures for COVID-19 have been arranged in most facilities. In many facilities, the timing of an infected employee's return to work was determined in accordance with the isolation period for coronavirus-positive patients with symptoms established by the Ministry of Health, Labor and Welfare in Japan. Approximately 30% of respondents reported that caring for COVID-19 patients, including the use of personal protective equipment, was their most stressful job. Approximately 50% of the respondents reported an increase in overtime hours. Approximately 90% of facilities are now capable of performing COVID-19 testing onsite.
Conclusion: Infection control for COVID-19 has been improved, and testing equipment for SARS-CoV-2 has been prepared. Patient care-related burdens and burdens caused by having to compensate for vacancies due to infected staff members have increased. In the future, a reduction in workload and role sharing should be considered.
Competing Interests: Declaration of competing interest The authors declare that they have no conflict of interest.
(Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: